Kestra Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.57M Sell
4,452
-2,407
-35% -$858K 0.03% 159
2025
Q4
$2.25M Sell
6,859
-545
-7% -$173K 0.05% 127
2025
Q3
$2.09M Sell
7,404
-5,980
-45% -$1.73M 0.06% 122
2025
Q2
$3.95M Buy
13,384
+6,901
+106% +$1.96M 0.06% 106
2025
Q1
$2.02M Buy
6,483
+2,905
+81% +$858K 0.06% 97
2024
Q4
$933K Buy
3,578
+147
+4% +$43.6K 0.04% 145
2024
Q3
$1.11M Buy
+3,431
New +$1.12M 0.05% 111

Other funds holding AMGN

Kestra Investment Management's AMGN Position: Q1 2026 in Review

Kestra Investment Management reduced its Amgen (AMGN) stake by 35% in Q1 2026, selling an estimated $858K and leaving 4,452 shares worth $1.57M. The position accounts for 0.03% of the portfolio, ranked #159.

Kestra Investment Management first reported a position in AMGN in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.95M in Q2 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Kestra Investment Management held 4,452 shares of Amgen worth $1.57M as of Q1 2026.
  • Kestra Investment Management sold 2,407 Amgen shares in Q1 2026, an estimated $858K.
  • Amgen made up 0.03% of Kestra Investment Management's portfolio in Q1 2026, its #159 holding.
  • Kestra Investment Management first reported a position in Amgen in Q3 2024 and has held it in 7 quarters since.
  • Kestra Investment Management's Amgen position peaked at $3.95M in Q2 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Kestra Investment Management's 13F filing for Q1 2026, filed 11 May 2026.